GALMED PHARMACEUTICALS LTD.

GLMD ·Healthcare, Drug Manufacturers - General, Israel
Financial Statements SEC Filings

SEC Filings

Form Filed Description
6-K Apr 14, 2026 6-K
6-K Apr 9, 2026 6-K
EFFECT Apr 1, 2026
POS AM Mar 31, 2026 POS AM
20-F Mar 31, 2026 20-F
3 Mar 18, 2026 3
3 Mar 18, 2026 3
3 Mar 18, 2026 3
3 Mar 18, 2026 3
3 Mar 18, 2026 3
3 Mar 18, 2026 3
3 Mar 18, 2026 3
3 Mar 18, 2026 3
3 Mar 18, 2026 3
6-K Mar 5, 2026 6-K
6-K Mar 4, 2026 6-K
6-K Feb 9, 2026 6-K
6-K Jan 30, 2026 6-K
6-K Dec 8, 2025 6-K
6-K Dec 4, 2025 6-K
6-K Dec 1, 2025 6-K
6-K Nov 26, 2025 6-K
6-K Nov 18, 2025 6-K
6-K Nov 17, 2025 6-K
SCHEDULE 13G/A Nov 7, 2025
← Newer Page 2 of 16 · 381 filings Older →